New Conferences
(8 records)
Page 1 of 1
Sort by :

   

Jun 08, 2018
Aug 21, 2018

SWEET BLOOD SEEBAI

  • Understand patient perspectives.
  • Treat the person not the numbers, and the numbers will come down!
  • Review preDM and diabetes prevention
  • Come out of it as better health care workers
David Dannenbaum MD, CCFP
diabeties indigenous, management
Jun 08, 2018
Aug 21, 2018

EARLY GESTATIONAL DIABETES MELLITUS (GDM)?

  • Review rationale for 2012 CBHSSJB Hyperglycemia in Pregnancy guidelines
  • Understand significance of eGDM
David Dannenbaum MD, CCFP
Jun 08, 2018
Aug 21, 2018

TYPE 2 DIABETES IN YOUTH: EPIDEMIOLOGY, TREATMENT AND EARLY LIFE DETERMINANTS

Dr. Sellers will briefly review the epidemiology of youth onset type 2 diabetes and focus on treatment and early life determinents of this emerging epidemic. Learning Objectives:
  • Review the epidemiology of childhood onset type 2 diabetes in Indigenous youth
  • To explore the reasons for an increased burden in Indigenous children
  • Develop an approach to treatment
  • Understand barriers to care
  • Explore early life determinants
Elizabeth Sellers MD MSc FRCPC
Type 2 diabetes, Children, Adolescents, Indigenous
Jun 08, 2018
Aug 21, 2018

NEW DIABETIC AGENTS... WHAT TO CHOSE?

  • Review current therapies to treat type 2 diabetes mellitus with emphasis on new agents
  • Review new landmark cardiovascular safety trials
  • Review 2018 CDA guidelines with respect to new targets for glycemic control
  • Provide some framework for choosing amongst the different agents
  • Review insulin initiation and the new insulins
Natasha Garfield, MDCM, FRCP(C)
diabetes, new medications, new insulins
Apr 25, 2018
Aug 20, 2018

THE ROLE OF NOVEL THERAPIES IN THE MANAGEMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA

  • Understanding treatment options in the management of frontline CLL and how to approach patient selection
  • Integrate the emerging data into clinical practice when providing treatment options to patients in the management of relapsed CLL and how to sequence therapies
  • Share experience and gain knowledge on best practices of effective management of adverse events associated with treatment options
Steven E Coutré MD Hematologist/ Leukemia Specialist Professor of Medicine (Hematology) Stanford University Medical Center
Apr 19, 2018
Aug 20, 2018

WHAT’S NEW IN THE MANAGEMENT OF UROTHELIAL CANCER

Will discuss topic such as:
  • Intravesical management
  • Cystectomies indications
  • Promises of immunotherapy in this context
Yves Fradet, MD, FRCS(C) Urologist-Oncologist Professor Department of Surgery, Division of Urology Laval University Head of the Urology Department of the CHU de Québec
Cystectomies, immunotherapy
Nov 16, 2017
Jun 14, 2018

SMOKING CESSATION

  • Understand the nature of nicotine dependence
  • Develop a personalized approach to treat tobacco use disorder
  • Understand the rationale for prescribing off-label pharmacotherapy
  • Apply optimal treatment in specific cases
Dr. Sean Gilman
Feb 28, 2018
Jun 13, 2018

ALTERNATIVE THERAPIES IN CANCER CARE – MARIJUANA AND BEYOND

  • Describe the pharmacology and pharmacodynamics of cannabinoids as complementary tools for symptom management and improvement of quality of life in palliative care patients.
  • Review current regulations and prescription protocols for cannabinoids in Quebec.
  • Develop a standardized approach for the integration of cannabinoids medicine into palliative and supportive care practices.
Dr. Antonio Vigano
cancer, MEDICAL CANNABIS, PALLIATIVE CARE, ENDOCANNABINOID, CB1 AND CB2 RECEPTORS, SYNTHETIC, CONTRAINDICATIONS, PRECAUTIONS

1

 

 

Copyright © 2002-2018 Continuing Professional Development (CPD) Office,
Faculty of Medicine, McGill University